Burke & Herbert EVP exercises stock rights, withholds shares
Burke & Herbert Financial Services Corp. executive Robert S. Tissue, EVP Financial Strategy, reported multiple equity transactions in Common Stock on July 17, 2026.
Rhea-AI Filing Summary
Burke & Herbert Financial Services Corp. executive Robert S. Tissue, EVP Financial Strategy, reported multiple equity transactions in Common Stock on July 17, 2026. He exercised stock-settled appreciation rights for 12,709 shares of Common Stock at exercise prices of $51.58 and $47.47 per share. As payment of exercise price or tax liability, 9,777 shares of Common Stock were delivered at $72.85 per share. Reported holdings include 53,858 Common shares held directly and 373 shares held indirectly by his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Settled Appreciation Rights | 8,599 | $0.00 | $0.00 |
| Exercise | Stock Settled Appreciation Rights | 4,110 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,599 | $47.47 | $408K |
| Exercise | Common Stock | 4,110 | $51.58 | $212K |
| Exercise Price or Tax Liability | Common Stock | 9,777 | $72.85 | $712K |
| holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
Stock Settled Appreciation Rights financial
tax-withholding disposition financial
indirect ownership financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did BHRB executive Robert S. Tissue report?
What were the exercise prices of Robert S. Tissue’s BHRB Stock Settled Appreciation Rights?
Were Robert S. Tissue’s BHRB transactions under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.